GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 206 Consolidated Statement of Cash Flows for the year ended March 31, 2022 ( ` in lakhs ) Year ended March 31, 2022 Year ended March 31, 2021 A. CASH FLOWS FROM OPERATING ACTIVITIES Profit before exceptional items and tax from : Continuing operations 767,47.15 626,58.74 Disontinued operations 1708,17.66 96,50.78 2475,64.81 723,09.52 Adjustments for : Gain on sale of brands and other identified assets (discontinued operations) (1635,65.34) - (Gain) / Loss on disposal of property, plant and equipment (net) (32.37) 5.88 Interest income (71,24.02) (110,57.49) Finance costs 1,99.61 3,53.14 Depreciation and amortisation expense 68,18.60 78,60.49 Allowance for doubtful debts and advances 16.17 2,06.05 Provision written back (0.67) - Depreciation expense related to discontinued operations 39.59 67.87 Operating Profit before working capital changes 839,16.38 697,45.46 Change in operating assets and liabilities Decrease/ (Increase) in inventories 12,00.27 (46,79.30) Decrease/ (Increase) in trade receivables 10,20.40 (99,93.42) (Increase) in other assets (16,23.49) (11,72.06) Increase in trade payables 102,37.49 107,40.97 Increase in provisions 71,28.11 27,08.09 (Decrease)/ Increase in other liabilities (59,75.60) 69,70.28 Cash generated from operations 959,03.56 743,20.02 Income taxes (paid) (net of refunds) (120,50.90) (146,96.18) Cash inflow from operating activities before exceptional items 838,52.66 596,23.84 Exceptional items: Payment of associated costs on sale of Vemgal Plant (4,42.88) (7,03.09) Payment of redundancy cost (31,63.26) (11,30.59) Income taxes on exceptional items 8,28.26 0.93 Net cash generated from operating activities A 810,74.78 577,91.09 B. CASH FLOWS FROM INVESTING ACTIVITIES Payments to acquire property, plant and equipment and other intangible assets (34,64.10) (44,22.66) Proceeds from sale of property, plant and equipment 1,17.72 67.20 Margin money deposits (placed) / matured (12.21) 14.33 Investment in bank deposits (having original maturity more than 3 months but less than 12 months) (2704,10.00) (3378,23.00) Redemption / maturity of bank deposits (having original maturity more than 3 months but less than 12 months) 1257,00.00 3603,24.45 Current Investments (365,27.51) - Loan given to related parties (190,00.00) - Net proceeds from sale of brands and other identified assets (Discontinued Operations) 1265,60.61 -